In prostate cancer, miR-223 suppressed tumor cell proliferation, migration, and invasion by targeting ITGA3/ITGB1 (integrin subunit alpha 3/ integrin subunit beta 1) signaling [26]. Here, ITGA3 is linked to neoplasm.